Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H14N4 |
| Molecular Weight | 154.2129 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)(C)NC(=N)NC#N
InChI
InChIKey=VZVGEDRCVUKSEL-UHFFFAOYSA-N
InChI=1S/C7H14N4/c1-4-7(2,3)11-6(9)10-5-8/h4H2,1-3H3,(H3,9,10,11)
| Molecular Formula | C7H14N4 |
| Molecular Weight | 154.2129 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of guancydine on systemic and renal hemodynamics in arterial hypertension. | 1977-06 |
|
| Guancydine, a new hypotensive agent with complex action. | 1977 |
|
| Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol. | 1972-04 |
|
| [Studies on the action of the antihypertensive agent guancydine. II. Potentiation of the effect by pretreatment with furosemide or mefruside in the rat]. | 1971 |
|
| Cardiovascular actions of guancydine in normotensive and hypertensive animals. | 1968-05 |
Sample Use Guides
The hypotensive effect of a single oral dose of 500-750 mg persists for about 6-7 hours after its administration. Guancydine does not impair the vasopressor response to angiotensin II but reduces the action of this peptide on the excretion of water, Na, K and Ca through urine.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:41:23 GMT 2025
by
admin
on
Mon Mar 31 18:41:23 GMT 2025
|
| Record UNII |
71Y9TQ5U2Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB07982MIG
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
C175080
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
1341
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
214-198-3
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
C100199
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
14211
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
DTXSID0023115
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
1113-10-6
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
100000084472
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL1697839
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
71Y9TQ5U2Z
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY | |||
|
2345
Created by
admin on Mon Mar 31 18:41:24 GMT 2025 , Edited by admin on Mon Mar 31 18:41:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
